NCT06911775View on ClinicalTrials.gov

Eosinophil Subpopulations in Eosinophilic-associated Diseases

Not yet recruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Eosinophilic AsthmaEosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)
Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Florence

OTHER